Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.
Search results for:

Hyoscyamine

hyoscyamine
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Hyosyne LIQUID, ORAL 0.125 mg/5 mL      
NuLev, Anaspaz, Ed Spaz, Oscimin, Symax FasTabs TABLET, DISINTEGRATING, ORAL 0.125 mg      
Levbid, Symax SR, Hyomax SR TABLET, EXTENDED RELEASE, ORAL 0.375 mg      
Levsin, Oscimin TABLET, ORAL 0.125 mg, 0.15 mg    
Levsin SL, HyoMax-SL, Oscimin, Symax-SL TABLET, SUBLINGUAL 0.125 mg    
VIEW MORE Antimuscarinics/Antispasmodics
CLASS
120808
Comments:

ORDERED FORMULATION

THERAPEUTIC INTERCHANGE

hyoscyamine (Levsin SL, HyoMax-SL, Oscimin, Symax-SL)

  • 0.125 mg sublingual tablet

hyoscyamine (NuLev)                                                                                                                

  • 0.125 disintegrating tablet oral

hyoscyamine (Levsin, Oscimin)

  • 0.125 mg tablet oral
  • 0.15 mg tablet oral

hyoscyamine (NuLev)

  • 0.125 disintegrating tablet oral
  • 0.125 disintegrating tablet oral

Reviewed: March 25, 2014 (Hyoscyamine Products Formulary)

Last updated: Jun. 27, 2017






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.

Copyright © 2024 Rpharmy, LLC ­ All Rights Reserved